Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Placebo for Multiple Rib Fractures
NCT04928300Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- Jun 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in rib fracture (2 arms), sponsored by Assiut University. Primary endpoint: Ultrasonographic diaphragm function at 5 days. Started Jun 2021; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04928300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04928300.